Menu Search
Equities

WELL Health Technologies Corp

W7V:STU

WELL Health Technologies Corp

Actions
  • Price (EUR)3.49
  • Today's Change0.072 / 2.10%
  • Shares traded3.00k
  • 1 Year change+19.83%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year WELL Health Technologies Corp had net income fall -94.01% from 1.37m to 82.00k despite a 36.36% increase in revenues from 569.14m to 776.05m. An increase in the cost of goods sold as a percentage of sales from 46.71% to 52.03% was a component in the falling net income despite rising revenues.
Gross margin44.16%
Net profit margin9.88%
Operating margin3.35%
Return on assets6.41%
Return on equity9.25%
Return on investment7.92%
More ▼

Cash flow in CADView more

In 2023, cash reserves at WELL Health Technologies Corp fell by 5.49m. However, the company earned 65.73m from its operations for a Cash Flow Margin of 8.47%. In addition the company generated 10.63m cash from financing while 81.32m was spent on investing.
Cash flow per share0.654
Price/Cash flow per share7.83
Book value per share3.40
Tangible book value per share-0.8131
More ▼

Balance sheet in CADView more

WELL Health Technologies Corp has a Debt to Total Capital ratio of 30.16%, a lower figure than the previous year's 47.81%.
Current ratio1.14
Quick ratio1.13
Total debt/total equity0.4679
Total debt/total capital0.3016
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.